The dual glucose‐dependent insulinotropic peptide and...

  • Main
  • 2020 / 09
  • The dual glucose‐dependent insulinotropic peptide and...
Diabetes, Obesity and Metabolism 2020 / 09

The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

Wilson, Jonathan M., Nikooienejad, Amir, Robins, Deborah A., Roell, William C., Riesmeyer, Jeffrey S., Haupt, Axel, Duffin, Kevin L., Taskinen, Marja‐Riitta, Ruotolo, Giacomo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.14174
Date:
September, 2020
File:
PDF, 872 KB
2020
Conversion to is in progress
Conversion to is failed